Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BC-23 (NSC 45382) is a potent proteasome inhibitor with antitumor and antimicrobial activity.BC-23 inhibits the CT-L activity of the proteasome and is used in the study of leukemias, lymphomas, gliomas, breast cancer, and small cell lung cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 100.00 | |
5 mg | In stock | $ 197.00 | |
10 mg | In stock | $ 318.00 | |
25 mg | In stock | $ 575.00 | |
50 mg | In stock | $ 860.00 | |
100 mg | 6-8 weeks | $ 1,290.00 |
Description | BC-23 (NSC 45382) is a potent proteasome inhibitor with antitumor and antimicrobial activity.BC-23 inhibits the CT-L activity of the proteasome and is used in the study of leukemias, lymphomas, gliomas, breast cancer, and small cell lung cancer. |
Synonyms | NSC 45382, BC 23, BC23, NSC-45382, NSC45382 |
Molecular Weight | 439.87 |
Formula | C21H14ClN3O4S |
CAS No. | 6298-15-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL(45.47 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BC-23 6298-15-3 Proteases/Proteasome Ubiquitination Proteasome NSC 45382 BC 23 BC23 NSC-45382 NSC45382 inhibitor inhibit